Lin Xia-Hui, Li Dong-Ping, Liu Zhi-Yong, Zhang Si, Tang Wen-Qing, Chen Rong-Xin, Weng Shu-Qiang, Tseng Yu-Jen, Xue Ru-Yi, Dong Ling
Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Shanghai Institute of Liver Disease, Shanghai, 200032, China.
Cancer Cell Int. 2023 Mar 23;23(1):52. doi: 10.1186/s12935-023-02888-9.
Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endogenous RNAs (ceRNA) mechanism plays a crucial role in HCC progression. However, the underlying mechanisms remain unclear.
Differentially expressed immune-related genes were obtained from the Immport, GEO, and TCGA databases. The mRNA and protein expression levels in HCC tissues and adjacent normal tissues were confirmed, and we further investigated the methylation levels of these biomarkers to explore their function. Then, the TIMER and TISCH databases were used to assess the relationship between immune infiltration and hub genes. Survival analysis and univariate and multivariate Cox models were used to evaluate the association between hub genes and HCC diagnosis. Hub gene expression was experimentally validated in six HCC cell lines and 15 HCC samples using qRT-PCR and immunohistochemistry. The hub genes were uploaded to DSigDB for drug prediction enrichment analysis.
We identified that patients with abnormal miRNAs (hsa-miR-125b-5p and hsa-miR-21-5p) and their targeted genes (NTF3, PSMD14, CD320, and SORT1) had a worse prognosis. Methylation analysis of miRNA-targeted genes suggested that alteration of methylation levels is also a factor in the induction of tumorigenesis. We also found that the development of HCC progression caused by miRNA-mRNA interactions may be closely correlated with the infiltration of immunocytes. Moreover, the GSEA, GO, and KEGG analysis suggested that several common immune-related biological processes and pathways were related to miRNA-targeted genes. The results of qRT-PCR, immunohistochemistry, and western blotting were consistent with our bioinformatics results, suggesting that abnormal miRNAs and their targeted genes may affect HCC progression.
Briefly, our study systematically describes the mechanisms of miRNA-mRNA interactions in HCC and predicts promising biomarkers that are associated with immune filtration for HCC progression.
最近的报告发现,异常的miRNA和mRNA表达以及失调的免疫微环境经常诱导肝细胞癌(HCC)进展。特别是,免疫相关的竞争性内源RNA(ceRNA)机制在HCC进展中起关键作用。然而,其潜在机制仍不清楚。
从Immport、GEO和TCGA数据库中获取差异表达的免疫相关基因。确认HCC组织和相邻正常组织中的mRNA和蛋白质表达水平,并进一步研究这些生物标志物的甲基化水平以探索其功能。然后,使用TIMER和TISCH数据库评估免疫浸润与枢纽基因之间的关系。生存分析以及单变量和多变量Cox模型用于评估枢纽基因与HCC诊断之间的关联。使用qRT-PCR和免疫组织化学在六种HCC细胞系和15个HCC样本中对枢纽基因表达进行实验验证。将枢纽基因上传到DSigDB进行药物预测富集分析。
我们发现,miRNA(hsa-miR-125b-5p和hsa-miR-21-5p)及其靶向基因(NTF3、PSMD14、CD320和SORT1)异常的患者预后较差。miRNA靶向基因的甲基化分析表明,甲基化水平的改变也是诱导肿瘤发生的一个因素。我们还发现,由miRNA-mRNA相互作用引起的HCC进展可能与免疫细胞浸润密切相关。此外,GSEA、GO和KEGG分析表明,几个常见的免疫相关生物学过程和途径与miRNA靶向基因有关。qRT-PCR、免疫组织化学和蛋白质印迹的结果与我们的生物信息学结果一致,表明异常的miRNA及其靶向基因可能影响HCC进展。
简而言之,我们的研究系统地描述了HCC中miRNA-mRNA相互作用的机制,并预测了与HCC进展免疫过滤相关的有前景的生物标志物。